Skip to content

NGEN - NERVGEN PHARMA CORP. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

NervGen Pharma Corp.

NGEN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NGENNervGen Pharma Corp.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $6.30
52-wk low: $1.58
Prev close: $4.44
Mkt cap: $188.2M
Beta: 0.69
P/B: 14.8x

Smart money

4 funds hold a position.

Real smart money

Funds holding this stock

4 holders

Combined position$1.4M

MW
Marshall Wace
Q2 2026 13F
$898K
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $188M

Valuation

P/B14.76

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NGEN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $188.16M
Beta: 0.69

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-757.0%

$82K

position

BO

Bank of America

Q2 2026 13F

$384K

position

1 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 1 holders

Coverage gaps for NGEN

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

Reports Aug 21, 2026, today

EPS expected

-$0.11

-$0.11 to -$0.11

Revenue expected

$0.00

5 analysts

Estimate drift

0.03

Change in 30 days

-757.0%

ROA-37.7%

Growth

Beta0.69